View in EDS

Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.

Saved in:
Bibliographic Details
Title: Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.
Authors: Schewe DM; Medical Faculty Otto-von-Guericke University Magdeburg Germany., Vogiatzi F; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Münnich IA; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Zeller T; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Windisch R; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Wichmann C; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Müller K; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Bhat H; Medical Faculty Otto-von-Guericke University Magdeburg Germany., Felix E; Medical Faculty Otto-von-Guericke University Magdeburg Germany., Mougiakakos D; Department of Hematology/Oncology Otto-von-Guericke University Magdeburg Germany., Bruns H; Department of Internal Medicine 5, Hematology and Oncology Friedrich-Alexander-University Erlangen-Nürnberg Erlangen Germany., Lenk L; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Valerius T; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Humpe A; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Peipp M; Division of Antibody-Based Immunotherapy, Department of Medicine II Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Kellner C; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany.
Source: HemaSphere [Hemasphere] 2024 Feb 22; Vol. 8 (2), pp. e48. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2572-9241
DOI:10.1002/hem3.48